Crucell convened a General Meeting of Shareholders on January 10, 2005, at which the exchange offer for Berna Biotech A.G. (Swiss Exchange: BBIN) was approved in accordance with Section 2:107a of the Dutch Civil Code.

In addition, Messrs. Dominik Koechlin, Jürg Witmer and Claude Thomann were appointed as members of the Supervisory Board of Crucell upon the exchange offer becoming or being declared unconditional.

Further, approval was received for the dismissal of Crucell’s external auditor, Ernst & Young, following many years of good cooperation. The Supervisory Board’s proposal was based on the advice of the Audit Committee and the Board of Management with regard to the desirability for a systematic rotation of the external auditor. Deloitte was subsequently appointed as Ernst & Young’s successor.

Video Webcast

The General Meeting of Shareholders was held in Dutch with an English translation available. Click on the link below to access both Dutch and English versions.

 

Video Webcast

 

(To view the video webcast, Java Runtime is required.)

Documentation

Documents relevant to the General Meeting of Shareholders are listed below.

English Versions:

Shareholders Circular

Convocation GM 10 January 2006

Agenda and Explanatory Notes GM 10 January 2006


Nederlandse versies:

Uitnodiging AVA 10 januari 2006

Agenda AVA 10 januari 2006


(All documents are PDF files. For PDF files, Adobe Acrobat is required.)